If not the world’s leading gene therapy research center, Nationwide Children’s Hospital seeks to aggressively expand into gene therapy research with the launch of a $74 million biotechnology manufacturing facility for genetic material used in research and clinical...
Gene Therapy Manufacturing
Category
With Big Wave of Gene Therapy Products Moving to Clinical Trials FDA Prepares with More Guidance
To date, the U.S. Food and Drug Administration (FDA) has approved four gene therapy products, which insert new genetic material into a patient’s cells. The agency expects a boom in gene therapy product approvals in the coming decade as evidenced by the more than 900...
UK Cell and Gene Therapy Production Sites Double in UK’s Bid to Compete in Industry
The UK’s Cell and Gene Catapult (CGT Catapult) completed six additional production modules in a bid for the UK to remain competitive in the booming cell and gene therapy drug development business. The first six clean room at capacity due to high demand at the...
Catalent Acquires Paragon Biosciences for $1.2 Billion: Race for Gene Therapy MFG Capacity
Lisa Urquhart reports that with the growing gene therapy development pipeline comes the need for manufacturing capacity. Will biopharma firms buy or build? Buy will often be the answer when feasible. The $1.2 billion all cash deal represents a considerable premium....